Analyst firms · H.C. Wainwright · OCUL
H.C. Wainwright OCUL price target and rating history
Ocular Therapeutix Inc. (OCUL) · Health Care
H.C. Wainwright rates Ocular Therapeutix Inc. (OCUL) Buy with a $14 price target, as of its latest action on Oct 25, 2021. It has published 3 rating actions on OCUL since August 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Buy
- Price target
- $14
- Median target, all firms
- Too few
- Actions on OCUL
- 3
H.C. Wainwright price target on OCUL
Every H.C. Wainwright rating on OCUL
- Oct 25, 2021
- Oct 12, 2021
- Aug 10, 2021
Questions about H.C. Wainwright and OCUL
- What is H.C. Wainwright's price target for OCUL?
- H.C. Wainwright's latest stated price target for Ocular Therapeutix Inc. (OCUL) is $14, from its action on Oct 25, 2021.
- What is H.C. Wainwright's rating on OCUL?
- H.C. Wainwright rates OCUL Buy, a bullish rating, as of Oct 25, 2021.
- When did H.C. Wainwright last change its view on OCUL?
- On Oct 25, 2021, H.C. Wainwright cuts its price target to $14 from $18, keeps Buy.
More OCUL rating histories
All H.C. Wainwright ratingsOCUL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.